Private Equity
ManchesterStory Venture has raised $41 million for its debut fund, according to an SEC filing. The target is $125 million. Based in West Des Moines, Iowa, ManchesterStory is a venture firm that invests in the fintech and healthcare sectors.
1 min read · 05 February 2018
Israel and Chicago-based MDClone, a healthcare IT startup, has raised $15 million in funding. The investors were OrbiMed Israel Partners and Lightspeed Venture Partners.
1 min read · 05 February 2018
6 min read · 05 February 2018
Joe Lonsdale's 8VC has set out to raise a $640 million second venture capital fund, according to a filing with the SEC.
1 min read · 02 February 2018
UK-based Medopad, a health tech AI company, has raised $28 million in funding. The investors included China’s NWS Holdings. UBS Limited was financial adviser to Medopad on the transaction.
5 min read · 02 February 2018
Cambridge, Massachusetts-based Moderna Therapeutics, a developer of messenger RNA therapeutics and vaccines, has raised $500 million in funding. The investors include a subsidiary of the Abu Dhabi Investment Authority, EDBI, Sequoia Capital China, Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
1 min read · 02 February 2018
Santa Monica, California-based incubator and venture firm Science Inc, an early investor in Dollar Shave Club, has wrapped up its second fund with $75 million in commitments, according to a regulatory filing. Twenty LPs committed to the fund, which was previously targeted at $60 million. Science, led by Mike Jones, Peter Pham, Greg Gilman and Tom Dare, has separately launched an incubator for blockchain startups.
1 min read · 02 February 2018
3 min read · 02 February 2018
Cambridge, Massachusetts-based Avrobio, a developer of gene therapies for rare diseases, has closed $60 million in Series B financing. Cormorant Asset Management and Surveyor Capital led the round with participation from other investors that included Aisling, Brace Pharma Capital, Eventide Asset Management, Morningside, Atlas Venture, SV Health Investors and Clarus Ventures.
1 min read · 01 February 2018
Jerusalem-based OurCrowd, a global equity crowdfunding platform, has launched its 13th fund ADvantage. The $50 million fund, which was co-founded with leAD Sports, a sports tech accelerator, will invest in early-stage sports tech companies.
4 min read · 01 February 2018
